Peripherally inserted central catheters versus implantable port catheters for cancer patients: a meta-analysis

被引:10
作者
Lin, Li [1 ]
Li, Wei [2 ]
Chen, Chen [1 ]
Wei, Anhua [2 ]
Liu, Yu [2 ]
机构
[1] Wuhan Asia Gen Hosp, Dept Oncol, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pharm, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
PICC; PORT; cancer; central venous access; meta-analysis; CENTRAL VENOUS CATHETERS; RETROSPECTIVE ANALYSIS; ACCESS DEVICES; COMPLICATIONS; CHEMOTHERAPY; RISK; BREAST; PICC; QUALITY;
D O I
10.3389/fonc.2023.1228092
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The implanted vascular access ports (PORTs) were compared with peripherally inserted central catheters (PICCs) as the administration of chemotherapy regarding different clinical effects and adverse effects. Which is better is debatable. Hence, the current study was conducted to assess the safety and efficacy of these two optimal vascular access strategies.Methods The following electronic databases were searched: PubMed, Embase, and the Cochrane Library updated in May 2023. Studies on the differences in complication rates in patients with cancer using either PICC or PORT for chemotherapy were included. Meta-analysis Revman 5.3 software was used for statistical analysis.Results A total of 22 articles were retrieved. The results suggested that PORT has a superior safety profile, with lower incidences of overall adverse effects (OR=2.72, 95% CI=1.56-4.72 P=0.0004), catheter-related thrombosis (OR=2.84, 95% CI=1.97-4.11, P<0.00001), and allergic reactions (OR=6.26, 95% CI=1.86-21.09, P=0.003) than typically expected with PICC. Moreover, PICC was non-inferior to the PORT group with respect to DVT (OR=2.00, 95% CI=0.86-4.65, P=0.11) and infection (OR=1.55, 95% CI=0.75-3.22, P=0.24).Conclusion PORT achieved safety benefits compared with chemotherapy through PICC. Therefore, PORT is regarded as safe and effective vascular access for the administration of chemotherapy. When considering economic factors and some key elements, more high-quality research would help verify these clinical benefits.Systematic review registration, identififier CRD42023421690.
引用
收藏
页数:10
相关论文
共 40 条
[1]   Utilization and Complications of Central Venous Access Devices in Oncology Patients [J].
Akhtar, Narmeen ;
Lee, Linda .
CURRENT ONCOLOGY, 2021, 28 (01) :367-377
[2]   Comparison of the Quality of Life of Patients with Breast or Colon Cancer with an Arm Vein Port (TIVAD) Versus a Peripherally Inserted Central Catheter (PICC) [J].
Burbridge, Brent ;
Lim, Hyun ;
Dwernychuk, Lynn ;
Le, Ha ;
Asif, Tehmina ;
Sami, Amer ;
Ahmed, Shahid .
CURRENT ONCOLOGY, 2021, 28 (02) :1495-1506
[3]  
Capozzi Vito Andrea, 2021, Acta Biomed, V92, pe2021257, DOI 10.23750/abm.v92i5.11844
[4]   High rate of complications associated with peripherally inserted central venous catheters in patients with solid tumours [J].
Cheong, K ;
Perry, D ;
Karapetis, C ;
Koczwara, B .
INTERNAL MEDICINE JOURNAL, 2004, 34 (05) :234-238
[5]   The Michigan Risk Score to predict peripherally inserted central catheter-associated thrombosis [J].
Chopra, V. ;
Kaatz, S. ;
Conlon, A. ;
Paje, D. ;
Grant, P. J. ;
Rogers, M. A. M. ;
Bernstein, S. J. ;
Saint, S. ;
Flanders, S. A. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (10) :1951-1962
[6]   Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis [J].
Chopra, Vineet ;
Anand, Sarah ;
Hickner, Andy ;
Buist, Michael ;
Rogers, Mary A. M. ;
Saint, Sanjay ;
Flanders, Scott A. .
LANCET, 2013, 382 (9889) :311-325
[7]   Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer [J].
Clatot, Florian ;
Fontanilles, Maxime ;
Lefebvre, Laureline ;
Lequesne, Justine ;
Veyret, Corinne ;
Alexandru, Cristina ;
Leheurteur, Marianne ;
Guillemet, Cecile ;
Gouerant, Sophie ;
Petrau, Camille ;
Thery, Jean-Christophe ;
Rigal, Olivier ;
Moldovan, Cristian ;
Tennevet, Isabelle ;
Rastelli, Olivier ;
Poullain, Amelie ;
Savary, Laetitia ;
Bubenheim, Michael ;
Georgescu, Dragos ;
Gouerant, Julien ;
Gilles-Baray, Marie ;
Di Fiore, Frederic .
EUROPEAN JOURNAL OF CANCER, 2020, 126 :116-124
[8]   A randomized trial comparing vascular access strategies for patients receiving chemotherapy with trastuzumab for early-stage breast cancer [J].
Clemons, Mark ;
Stober, Carol ;
Kehoe, Anne ;
Bedard, Debbie ;
MacDonald, Fiona ;
Brunet, Marie-Claude ;
Saunders, Deanna ;
Vandermeer, Lisa ;
Mazzarello, Sasha ;
Awan, Arif ;
Basulaiman, Bassam ;
Robinson, Andrew ;
Mallick, Ranjeeta ;
Hutton, Brian ;
Fergusson, Dean .
SUPPORTIVE CARE IN CANCER, 2020, 28 (10) :4891-4899
[9]   Appraising the Quality of Medical Education Research Methods: The Medical Education Research Study Quality Instrument and the Newcastle-Ottawa Scale-Education [J].
Cook, David A. ;
Reed, Darcy A. .
ACADEMIC MEDICINE, 2015, 90 (08) :1067-1076
[10]   Comparison of outcomes of central venous catheters in patients with solid and hematologic neoplasms: an Italian real-world analysis [J].
Corti, Francesca ;
Brambilla, Marta ;
Manglaviti, Sara ;
Di Vico, Laura ;
Pisanu, Maria Neve ;
Facchinetti, Claudia ;
Dotti, Katia Fiorella ;
Lanocita, Rodolfo ;
Marchiano, Alfonso ;
de Braud, Filippo ;
Ferrari, Laura Anna Maria .
TUMORI JOURNAL, 2021, 107 (01) :17-25